WhatsApp
backNews Article

Gland Pharma Secures Overwhelming Approval to Appoint Mr. Xingli Wang as Non-Executive Director

Postal ballot remote e-voting results show 97.07% votes in favor, confirming appointment in November 2026

Gland Pharma Limited announced the appointment of Mr. Xingli Wang as Non-Executive and Non-Independent Director after securing over 97% member approval through remote e-voting in a postal ballot conducted in November 2026. The resolution passed with extensive shareholder participation, including promoter and institutional investors.

06 Nov 2026|GLAND+0.35%
Gland Pharma LimitedGLANDChange in Management

Gland Pharma Limited

Change in Management

Gland Pharma Limited announced that its members have approved the appointment of Mr. Xingli Wang as a Non-Executive and Non-Independent Director, with the resolution passing by a large majority in a postal ballot held on November 5, 2026.

The postal ballot voting was conducted remotely via electronic voting, covering promoter groups, public institutions, and non-institutional shareholders.

Voting results showed nearly 85.56% of total outstanding shares participated, with approximately 97.07% of votes in favor of the appointment resolution.

Promoter and promoter group shareholders accounted for almost 99.9999% in favor, while public institutional shareholders voted with 93.69% in favor, and public non-institutional shareholders voted 99.75% in favor.

The resolution was passed as an ordinary resolution under the SEBI Listing Regulations and the Companies Act, 2013.

The appointment was scrutinized by D Soumya, Company Secretary and Associate Partner of RVR & Associates, who confirmed the proper conduct and fairness of the voting process.

Highlights

  • Resolution to appoint Mr. Xingli Wang as Non-Executive and Non-Independent Director passed on November 5, 2026.
  • Approximate 85.56% of total outstanding shares participated in voting through remote e-voting.
  • Overall 97.07% votes cast were in favor of the resolution.
  • Promoter and promoter group voted 99.9999% in favor, with no votes against.
  • Public institutions voted 93.69% in favor and 6.31% against; public non-institutions voted 99.75% in favor.
  • Scrutinizer report from RVR & Associates confirmed transparent and compliant process.

Key Data Snapshot

Date of postal ballot conclusion05-11-2026
Voting participation as % of outstanding shares85.5557%
Votes in favor of appointment137038770
Votes against appointment4137395
Promoter group votes in favor75496894
Public institutions votes in favor61402485
Public non-institutions votes in favor139391

What happened

  • Gland Pharma Limited's shareholders approved the appointment of Mr. Xingli Wang as a Non-Executive and Non-Independent Director through a postal ballot conducted by remote e-voting ending November 5, 2026.
  • The voting resolution passed with over 97% votes in favor from all shareholders participating.

Key details

  • Total voting turnout represented about 85.56% of the company's outstanding shares.
  • Promoter and promoter group shareholders voted nearly unanimously in favor, with 99.9999% support.
  • Public institutional shareholders voted 91.20% on shares held with 93.69% approval for the resolution.
  • Public non-institution shareholders voted with 0.79% participation and 99.75% approval.
  • The appointment is classified as an ordinary resolution under SEBI regulations and company bylaws.

Regulatory and governance context

  • The vote was conducted under the framework of the Companies Act, 2013, SEBI Listing Regulations 2015, and applicable MCA Circulars dating up to 2025.
  • The scrutiny and certification of the voting process were performed by D Soumya, Company Secretary in whole-time practice and Associate Partner at RVR & Associates.
  • The appointment complies with mandates for board composition reflecting non-executive and non-independent directorships.

More News on Change in Management

View all

Latest corporate announcements and market updates in Change in Management.

View all news
Gland Pharma Secures Overwhelming Approval to Appoint | Stockk News